Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04649385
Brief Title: BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

First Submitted : November 25, 2020
First Submitted that Met QC Criteria : November 25, 2020
First Posted : December 2, 2020

Last Update Submitted that Met QC Criteria : July 15, 2021
Last Update Posted : July 19, 2021